When Will Retatrutide Be FDA Approved
Given that sensory or gastrointestinal adverse effects, such as dysgeusia and persistent nausea, can impair nutritional intake and lead to early treatment discontinuation (particularly in vulnerable populations) future research must incorporate rigorous sensory testing, larger and more diverse cohorts, and adherence-related outcomes to clarify how incretin therapies influence taste perception and long-term eating behavior (153, 157, 161)
This outcome positions retatrutide as a highly effective candidate, potentially more so than current treatments like semaglutide (Wegovy) and tirzepatide (Zepbound)
W.BatterhamR
This rides the GLP-1 arm, so it is light at the bottom of the ladder and stronger higher up
Feb 25, 2025, 09:00 ET Physician-Developed Supplement Harnesses Cutting-Edge Science to Optimize Digestion, Metabolism, and Overall Wellness BIRMINGHAM, Ala., Feb